DISCLOSURES Past performance is not indicative of future results. Mention of companies/stocks herein is for illustrative purposes only and should not be interpreted as...
Dear International Growth Fund Shareholder: Baron International Growth Fund® (BINIX, the Fund) gained 8.07% (Institutional Shares) during the third quarter of 2024, while its...
This article was written by Follow Striving to uncover long-term investment opportunities (10+ years) through in-depth research and analysis. Nexus Research seeks to evaluate...
Listen on the go! Subscribe to Wall Street Breakfast on Apple Podcasts and Spotify This is an abridged conversation from Seeking Alpha’s Investing Experts...
Co-authored with “Hidden Opportunities.” The U.S. economy continues to slow down as the Federal Reserve continues its inflation containment efforts. While rates have been...
As fears about Beijing’s potential invasion of Taiwan once again gain traction and prompt investors like Warren Buffett to unwind their long positions in...
Kinnate Biopharma (NASDAQ:KNTE) develops small molecule kinase inhibitors to treat genomically defined cancers. The company has two molecules in the clinic, exarafenib and KIN-3248....
Having a good investment philosophy matters as much as picking the “right” stocks. That’s because even dominant companies can fall on hard times due...
She doesn’t know how much her student-loan bill will be when the years-long pandemic-era freeze on payments ends. Eminger’s loans were transferred during the...